Scientists are searching for reactive oxygen species, which have been associated with various health issues like heart problems, neurological disorders, inflammation, and aging. Salen complexes have proven to be effective in multiple oxidative stress situations and have been used as catalase and superoxide mimetics. To explore this further, three mixed complexes were synthesized using a Schiff base (salen) and a sugar (d-glucose) with Co(II), Ni(II), and Cu(II) ions. These complexes were then diagnosed by different analytical and spectral techniques. Stoichiometry, stereochemistry, some physical properties, and the method of bonding complexes were measured. Comparisons of the IR and ¹HNMR spectra of the ligands with the complexes demonstrated the involvement of the azomethine group of the ligand in the chelation process. The mass spectra and TGA agree with the proposed formula of the complexes, and the conductivity and UV–Vis data supported the octahedral geometry of the complexes, and information was obtained from partial parameter calculations by molecular modeling. The metal complexes exhibited strong antimicrobial and antioxidant properties when compared to standard drugs. The like-superoxide and catalyst mimetic complexes were screened using DPPH ABTS, revealing their effectiveness.

Enticed by the present scenario of infectious diseases, four new Co(II), Ni(II), Cu(II), and Cd(II) complexes of Schiff base ligand were synthesized from 6,6′-((1E-1′E)(phenazine-2,3-dielbis(azanylidene)-bis-(methanylidene)-bis-(3-(diethylamino)phenol)) (H ₂ L) to ascertain as effective drug for antituberculosis, anti-inflammatory, antioxidant, cytotoxic and antimicrobial activities. The organic ligand and its metal(II) complexes were characterized by numerous physical and spectroscopic methods, which showed that the complexes have a general formula, [ML], (where M = Co(II) (C1), Ni(II) (C2), Cu(II) (C3) and Cd(II) (C4)), for metal complexes have been proposed and have a square planar geometry, are amorphous in nature, and are thermally stable. Data highlight obtained from activity testing against tuberculosis, inflammation, and oxidants that all compounds are significantly active against these symptoms. Also, was to evaluate the effectiveness of various compounds against bacterial and fungal strains. Specifically, four bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa) and two fungal strains (Aspergillus flavus and Candida albicans) were tested and compared to the results of some standard drugs. The results revealed that compound C4 was more effective against bacterial strains than the comparison standard drugs. In addition, C3 was found to be the most effective of the comparison antibiotics against fungi, while the other compounds showed moderate antifungal activity. Moreover, to support the vitro results, certain computational studies as molecular docking studies, DFT, MESP, and AMEDT were also conducted to confirm the effectiveness of an organic ligand and its complexes against tuberculosis. These studies revealed that C4 is the most effective against tuberculosis and has desirable effects such as absorption, no degradation and no hepatotoxicity, etc.

In this study, we prepared 4-chlorophenylazoquinoline, a derivative of 8-hydroxyquinoline, with Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions to create metal complexes. We used various physical and spectroscopic methods to characterize the compound and its metal complexes, including molar conductivity measurements, melting point analysis, elemental analysis, electronic absorption spectroscopy, mass spectrometry, magnetic resonance spectroscopy, infrared spectroscopy, and thermogravimetric analysis. The octahedral geometry of all prepared complexes has been confirmed. To assess the antimicrobial activity, we examined two types of bacterial strains and two types of fungal strains. The antimicrobial activity of the prepared compounds was observed, and the higher increase was observed in the copper complex. The compounds were studied computationally after optimizing the angles, lengths, and bonds using the basic set 6-31G(d,p)/LANL2DZ. The molecular docking study of the compounds with the Alzheimer's disease protein 4BDT showed significant activity in binding to the amino acids of HL, C1, C2, C3, C4, and C5 compounds, with affinity energies of -6.4, -6.9, -6.9, -6.7, and -7.2 kcal.mol-1 for the compounds, respectively. To evaluate the safety of the prepared compounds in different drug designs, we employed the ADMET study, reducing the risk of failure in advanced drug design stages. The results of the ADMET showed a relative decrease in the toxicity and carcinogenicity factor. However, there are indications of metabolic risk and cellular uptake, requiring further study.